Helicobacter pylori infection and arterial stiffness in patients with type 2 diabetes mellitus

Metabolism: Clinical and Experimental

Volumn 57, Issue 12, 2008, Pages 1760-1764

  Ohnishi, Masayoshi ^a   Fukui, Michiaki ^b   Ishikawa, Takeshi ^a   Ohnishi, Nahoko ^b   Ishigami, Noriko ^a   Yoshioka, Keiji ^a   Hasegawa, Goji ^b   Yoshikawa, Toshikazu ^b   Nakamura, Naoto ^b  

^a MATSUSHITA MEMORIAL HOSPITAL   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTERIAL STIFFNESS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE; SYSTOLIC BLOOD PRESSURE;

AGED; ARTERIES; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HEART RATE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; VASCULAR RESISTANCE;

EID: 55649093304     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.08.001     Document Type: Article

References (36)

1. Ross R. Mechanism of disease: atherosclerosis-an inflammatory disease. N Engl J Med 340 (1999) 115-126
2. Epstein S.E., Zhon Y.F., and Zhu J. Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100 (1999) e20-e28
3. Patel P., Mendall M.A., Carrington D., et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ 311 (1995) 711-714
4. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. C reactive protein and its relation to cardiovascular risk factors. BMJ 312 (1996) 1061-1065
5. Farsak B., Yildirir A., Akyon Y., et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 38 (2000) 4408-4411
6. Sung J.J., and Sanderson J.E. Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart 76 (1996) 305-307
7. de Luis D.A., de la Calle H., Roy G., et al. Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 39 (1998) 143-146
8. Ojetti V., Pitocco D., Bartolozzi F., et al. High rate of Helicobacter pylori re-infection in patients affected by type 1 diabetes. Diabetes Care 25 (2002) 1485
9. Oldenburg B., Diepersloot R.J., and Hoekstra J.B. High seroprevalence of Helicobacter pylori in diabetes mellitus patients. Dig Dis Sci 41 (1996) 458-461
10. Isomaa B., Almgren P., Tuomi T., et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24 (2001) 683-689
11. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes in mortality results. JAMA 248 (1982) 1465-1470
12. Yamashina A., Tomiyama H., Arai T., et al. Brachial-ankle pulse wave velocity as a marker of atherosclerosis vascular damage and cardiovascular risk. Hypertens Res 26 (2003) 615-622
13. Kawai T., Kawakami K., Kudo T., Ogiahara S., Handa Y., and Moriyasu F. A new serum antibody test kit (E plate) for evaluation of Helicobacter pylori eradication. Intern Med 41 (2002) 780-783
14. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 25 (2002) 5-20
15. Leng G.C., Fowkes F.G.R., Lee A.J., Dunbar J., Housley E., and Ruckley C.V. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 313 (1996) 1440-1444
16. Yamashina A., Tomiyama H., Takeda K., et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25 (2002) 359-364
17. Pasceri V., Cammarota G., Patti G., et al. Association of virulent H. pylori strains with ischemic heart disease. Circulation 97 (1998) 1675-1679
18. Singh R.K., McMahon A.D., Patel H., Packard C.J., Rathbone B.J., and Samani N.J. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart 88 (2002) 43-46
19. Markus H.S., and Mendall M.A. Helicobacter pylori infection: a risk factor for ischemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 64 (1998) 104-107
20. Kinjo K., Sato H., Sato H., et al., Osaka Acute Coronary Insufficiency Study (OACIS) Group. Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial interaction. Circ J 66 (2002) 805-810
21. Wald N.J., Law M.R., Morris J.K., and Bagnall A.M. Helicobacter pylori infection and mortality from ischemic heart disease: negative result from a large, prospective study. BMJ 315 (1997) 1199-1201
22. Atherton J.C., Cao P., Peek Jr. R.M., Tummuru M.K., Blaser M.J., and Cover T.L. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori: association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 270 (1995) 17771-17777
23. Blaser M.J., Perez-Perez G.I., Kleanthous H., et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55 (1995) 2111-2115
24. Ito Y., Azuma T., Ito S., et al. Analysis and typing of the vacA gene from cagA-positive strains of Helicobacter pylori isolated in Japan. J Clin Microbiol 35 (1997) 1710-1714
25. Covacci A., Censini S., Bugnoli M., et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 90 (1993) 5791-5795
26. Correa P. A human model of gastric carcinogenesis. Cancer Res 48 (1988) 3554-3560
27. Kowalski M. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 52 (2001) 3-31
28. Davies M.J., Gordon J.L., Gearing A.J., et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol 171 (1993) 223-229
29. Ameriso S.F., Fridman E.A., Leiguarda R.C., and Sevlever G.E. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32 (2001) 385-391
30. Crabtree J.E., Shallcross T.M., Heatley R.V., and Wyatt J.I. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 32 (1991) 1473-1477
31. Moss S.F., Legon S., Davies J., and Calam J. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut 35 (1994) 1567-1570
32. Mendall M.A., Goggin P.M., Molineaux N., et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 71 (1994) 437-439
33. Takashima T., Adachi K., Kawamura A., et al. Cardiovascular risk factors in subjects with Helicobacter pylori infection. Helicobacter 7 (2002) 86-90
34. Scharnagl H., Kist M., Grawitz A.B., Koenig W., Wieland H., and Marz W. Effect of Helicobacter pylori eradication on high-density lipoprotein cholesterol. Am J Cardiol 93 (2004) 219-220
35. Kannel W.B. Lipids, diabetes, and coronary heart disease: insights from the Framingham Study. Am Heart J 110 (1985) 1100-1107
36. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339 (1998) 229-234